Shandong Weigao Group Medical Polymer Company Limited (1066.HK)

Name: Shandong Weigao Group Medical Polymer Company Limited Financial Statements
Creator: Quarter Results

Healthcare | Medical Instruments Supplies

Latest reporting period: 2026-04-08

Latest Quarter

2026-04-08

Revenue

$6.6B

Net Income

$1.0B

Operating Margin

17.7%

Free Cash Flow

$2.2B

Debt / Assets

27.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Income Statement (Quarterly)	2026-04-08	2025-06-30	2025-03-31	2024-12-31
Revenue	6,644,048,000	6,644,048,000	3,322,024,000	3,225,691,500
Cost of Revenue	3,340,540,000	3,340,540,000	1,670,270,000	1,646,080,500
Gross Profit	3,303,508,000	3,303,508,000	1,651,754,000	1,579,611,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,812,231,000	1,812,231,000	906,115,500	912,890,500
Operating Expenses	2,127,763,000	2,127,763,000	1,063,881,500	1,074,700,500
Operating Income	1,175,745,000	1,175,745,000	587,872,500	504,910,500
Interest Expense	0	116,773,000	0	0
Income Before Tax	1,225,904,000	1,225,904,000	612,952,000	593,684,500
Income Tax Expense	168,919,000	168,919,000	84,459,500	89,111,500
Net Income	1,008,317,000	1,008,317,000	504,158,500	479,559,500
Per Share
EPS	0.22	0.22	0.11	0.10
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Income Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	13,087,071,000	13,229,453,000	13,619,007,000	13,151,719,000	11,345,252,000
Cost of Revenue	6,506,440,000	6,586,420,000	6,505,925,000	5,882,315,000	4,887,962,000
Gross Profit	6,580,631,000	6,643,033,000	7,113,082,000	7,269,404,000	6,457,290,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	3,628,787,000	3,832,220,000	3,543,766,000	3,773,472,000	3,657,329,000
Operating Expenses	4,194,457,000	4,345,928,000	3,965,620,000	4,152,392,000	3,966,993,000
Operating Income	2,386,174,000	2,180,397,000	3,561,415,000	3,117,012,000	2,490,297,000
Interest Expense	249,572,000	272,971,000	191,401,000	140,396,000	178,935,000
Income Before Tax	2,553,748,000	2,369,187,000	3,317,901,000	2,841,721,000	2,496,029,000
Income Tax Expense	391,032,000	307,585,000	424,267,000	415,093,000	345,638,000
Net Income	2,066,668,000	2,001,906,000	2,723,309,000	2,244,778,000	2,030,137,000
Per Share
EPS	0.46	0.44	0.60	0.50	0.45
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	7,780,310,000	6,988,731,000	6,862,278,000	6,628,927,000
Short Term Investments	541,498,000	344,582,000	495,337,000	429,752,000
Net Receivables	7,455,486,000	5,960,128,000	5,735,233,000	0
Inventory	2,528,425,000	2,495,352,000	2,315,343,000	1,734,557,000
Total Current Assets	19,442,540,000	18,634,291,000	18,090,392,000	16,113,346,000
Property Plant Equipment	7,084,117,000	7,006,731,000	7,313,003,000	6,663,417,000
Goodwill and Intangibles	5,135,409,000	5,064,970,000	5,360,917,000	5,147,074,000
Total Assets	34,759,849,000	33,670,231,000	33,195,926,000	30,367,058,000
Liabilities
Account Payables	4,294,068,000	4,319,784,000	1,809,704,000	1,733,440,000
Short Term Debt	1,241,799,000	2,573,337,000	990,131,000	624,316,000
Total Current Liabilities	6,080,504,000	7,582,041,000	5,934,523,000	5,112,975,000
Long Term Debt	2,951,347,000	1,595,980,000	3,501,266,000	3,513,094,000
Total Liabilities	9,418,283,000	9,677,526,000	9,749,323,000	9,459,608,000
Shareholders Equity
Retained Earnings	19,852,418,000	18,627,532,000	17,312,614,000	0
Total Shareholders Equity	23,751,643,000	22,449,121,000	21,668,937,000	19,267,091,000

Balance sheet annual history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	7,780,310,000	6,988,731,000	6,862,278,000	6,628,927,000	5,514,331,000
Short Term Investments	541,498,000	344,582,000	495,337,000	429,752,000	469,610,000
Net Receivables	7,455,486,000	5,960,128,000	5,735,233,000	0	0
Inventory	2,528,425,000	2,495,352,000	2,315,343,000	1,734,557,000	1,504,126,000
Total Current Assets	19,442,540,000	18,634,291,000	18,090,392,000	16,113,346,000	14,125,215,000
Property Plant Equipment	7,084,117,000	7,006,731,000	7,313,003,000	6,663,417,000	6,069,713,000
Goodwill and Intangibles	5,135,409,000	5,064,970,000	5,360,917,000	5,147,074,000	5,155,401,000
Total Assets	34,759,849,000	33,670,231,000	33,195,926,000	30,367,058,000	27,344,669,000
Liabilities
Account Payables	4,294,068,000	4,319,784,000	1,809,704,000	1,733,440,000	1,837,959,000
Short Term Debt	1,241,799,000	2,573,337,000	990,131,000	624,316,000	306,473,000
Total Current Liabilities	6,080,504,000	7,582,041,000	5,934,523,000	5,112,975,000	4,499,416,000
Long Term Debt	2,951,347,000	1,595,980,000	3,501,266,000	3,513,094,000	4,014,525,000
Total Liabilities	9,418,283,000	9,677,526,000	9,749,323,000	9,459,608,000	8,954,215,000
Shareholders Equity
Retained Earnings	19,852,418,000	18,627,532,000	17,312,614,000	0	0
Total Shareholders Equity	23,751,643,000	22,449,121,000	21,668,937,000	19,267,091,000	18,390,454,000

Cash flow quarterly history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	2,553,748,000	2,369,187,000	3,317,901,000	2,244,778,000
Depreciation & Amortization	971,796,000	911,704,000	802,512,000	723,813,000
Stock Based Compensation	36,020,000	55,459,000	91,767,000	76,492,000
Change in Working Capital	-291,727,000	-315,232,000	-1,136,557,000	-204,934,000
Operating Cash Flow	2,789,971,000	2,798,529,000	2,214,574,000	3,035,163,000
Investing Activities
Capital Expenditure	-596,714,000	-685,664,000	-1,116,239,000	-1,116,882,000
Investments	-596,714,000	-647,577,000	-1,116,239,000	-1,070,684,000
Investing Cash Flow	-1,104,415,000	-1,388,592,000	-2,568,963,000	-1,479,374,000
Financing Activities
Debt Repayment	-102,002,000	-364,530,000	-874,672,000	-706,641,000
Common Stock Issued/Repurchased	-30,434,000	-36,530,000	-70,496,000	188,461,000
Dividends Paid	-870,588,000	-732,633,000	-741,638,000	-653,288,000
Financing Cash Flow	-1,595,939,000	-2,157,858,000	-1,020,957,000	-538,080,000
Summary
Free Cash Flow	2,191,925,000	2,112,865,000	1,098,335,000	1,918,281,000
Net Change in Cash	145,421,000	-723,590,000	-1,279,186,000	963,271,000

Cash flow annual history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	2,553,748,000	2,369,187,000	3,317,901,000	2,244,778,000	2,030,137,000
Depreciation & Amortization	971,796,000	911,704,000	802,512,000	723,813,000	690,694,000
Stock Based Compensation	36,020,000	55,459,000	91,767,000	76,492,000	30,662,000
Change in Working Capital	-291,727,000	-315,232,000	-1,136,557,000	-204,934,000	-262,948,000
Operating Cash Flow	2,789,971,000	2,798,529,000	2,214,574,000	3,035,163,000	2,696,608,000
Investing Activities
Capital Expenditure	-596,714,000	-685,664,000	-1,116,239,000	-1,116,882,000	-995,625,000
Investments	-596,714,000	-647,577,000	-1,116,239,000	-1,070,684,000	-935,598,000
Investing Cash Flow	-1,104,415,000	-1,388,592,000	-2,568,963,000	-1,479,374,000	423,221,000
Financing Activities
Debt Repayment	-102,002,000	-364,530,000	-874,672,000	-706,641,000	-2,593,945,000
Common Stock Issued/Repurchased	-30,434,000	-36,530,000	-70,496,000	188,461,000	258,763,000
Dividends Paid	-870,588,000	-732,633,000	-741,638,000	-653,288,000	-701,349,000
Financing Cash Flow	-1,595,939,000	-2,157,858,000	-1,020,957,000	-538,080,000	-1,793,841,000
Summary
Free Cash Flow	2,191,925,000	2,112,865,000	1,098,335,000	1,918,281,000	1,700,983,000
Net Change in Cash	145,421,000	-723,590,000	-1,279,186,000	963,271,000	0